These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 32702586
1. Anticancer property of ginsenoside Rh2 from ginseng. Li X, Chu S, Lin M, Gao Y, Liu Y, Yang S, Zhou X, Zhang Y, Hu Y, Wang H, Chen N. Eur J Med Chem; 2020 Oct 01; 203():112627. PubMed ID: 32702586 [Abstract] [Full Text] [Related]
2. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future. Guan W, Qi W. Phytomedicine; 2023 Sep 01; 118():154938. PubMed ID: 37406390 [Abstract] [Full Text] [Related]
3. Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review). Zhang H, Park S, Huang H, Kim E, Yi J, Choi SK, Ryoo Z, Kim M. Oncol Rep; 2021 Apr 01; 45(4):. PubMed ID: 33649861 [Abstract] [Full Text] [Related]
4. Anticancer Effects of Ginsenoside Rh2: A Systematic Review. He XL, Xu XH, Shi JJ, Huang M, Wang Y, Chen X, Lu JJ. Curr Mol Pharmacol; 2022 Apr 01; 15(1):179-189. PubMed ID: 33687905 [Abstract] [Full Text] [Related]
5. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis. Gao H, Liang D, Li C, Xu G, Jiang M, Li H, Yin J, Song Y. Biomed Pharmacother; 2020 Apr 01; 124():109891. PubMed ID: 31991384 [Abstract] [Full Text] [Related]
6. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice. Lv Q, Rong N, Liu LJ, Xu XL, Liu JT, Jin FX, Wang CM. Planta Med; 2016 May 01; 82(8):705-11. PubMed ID: 27163230 [Abstract] [Full Text] [Related]
7. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells. Han S, Jeong AJ, Yang H, Bin Kang K, Lee H, Yi EH, Kim BH, Cho CH, Chung JW, Sung SH, Ye SK. J Ethnopharmacol; 2016 Dec 24; 194():83-90. PubMed ID: 27566200 [Abstract] [Full Text] [Related]
8. Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation. Xiaodan S, Ying C. Biomed Pharmacother; 2022 Dec 24; 156():113912. PubMed ID: 36288668 [Abstract] [Full Text] [Related]
9. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells. Liu J, Shimizu K, Yu H, Zhang C, Jin F, Kondo R. Fitoterapia; 2010 Oct 24; 81(7):902-5. PubMed ID: 20554003 [Abstract] [Full Text] [Related]
10. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells. Kitts DD, Popovich DG, Hu C. Can J Physiol Pharmacol; 2007 Nov 24; 85(11):1173-83. PubMed ID: 18066119 [Abstract] [Full Text] [Related]
11. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study. Zare-Zardini H, Alemi A, Taheri-Kafrani A, Hosseini SA, Soltaninejad H, Hamidieh AA, Haghi Karamallah M, Farrokhifar M, Farrokhifar M. Drug Des Devel Ther; 2020 Nov 24; 14():3315-3324. PubMed ID: 32884236 [Abstract] [Full Text] [Related]
12. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. Cancer Chemother Pharmacol; 2007 Apr 24; 59(5):589-601. PubMed ID: 16924497 [Abstract] [Full Text] [Related]
13. Red ginseng and cancer treatment. Wang CZ, Anderson S, DU W, He TC, Yuan CS. Chin J Nat Med; 2016 Jan 24; 14(1):7-16. PubMed ID: 26850342 [Abstract] [Full Text] [Related]
14. Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: An updated review. Xu W, Lyu W, Duan C, Ma F, Li X, Li D. Fitoterapia; 2023 Jun 24; 167():105514. PubMed ID: 37084851 [Abstract] [Full Text] [Related]
15. Inhibition of autophagy potentiates anticancer property of 20(S)-ginsenoside Rh2 by promoting mitochondria-dependent apoptosis in human acute lymphoblastic leukaemia cells. Xia T, Wang J, Wang Y, Wang Y, Cai J, Wang M, Chen Q, Song J, Yu Z, Huang W, Fang J. Oncotarget; 2016 May 10; 7(19):27336-49. PubMed ID: 27027340 [Abstract] [Full Text] [Related]
16. Efficient thermal deglycosylation of ginsenoside Rd and its contribution to the improved anticancer activity of ginseng. Kim YJ, Yamabe N, Choi P, Lee JW, Ham J, Kang KS. J Agric Food Chem; 2013 Sep 25; 61(38):9185-91. PubMed ID: 23984628 [Abstract] [Full Text] [Related]
17. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Lee WK, Kao ST, Liu IM, Cheng JT. Horm Metab Res; 2007 May 25; 39(5):347-54. PubMed ID: 17533576 [Abstract] [Full Text] [Related]
18. Potential of ginsenoside Rh2and its derivatives as anti-cancer agents. Li K, Li Z, Men L, Li W, Gong X. Chin J Nat Med; 2022 Dec 25; 20(12):881-901. PubMed ID: 36549803 [Abstract] [Full Text] [Related]
19. Ginsenosides in cancer: Proliferation, metastasis, and drug resistance. Yang Y, Nan Y, Du Y, Liu W, Ning N, Chen G, Gu Q, Yuan L. Biomed Pharmacother; 2024 Aug 25; 177():117049. PubMed ID: 38945081 [Abstract] [Full Text] [Related]
20. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells. Popovich DG, Kitts DD. J Biochem Mol Toxicol; 2004 Aug 25; 18(3):143-9. PubMed ID: 15252870 [Abstract] [Full Text] [Related] Page: [Next] [New Search]